Bumper Offer - Urjas oil Just @ Rs. 1 X
Glipon MF 20/500 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Glipon MF 20/500 Tablet is used -
Severe
Moderate
Mild
Common
Unknown
Is the use of Glipon MF 20/500 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Glipon MF. It is best to stop taking Glipon MF immediately and inform your doctor if you notice any discomfort.
Is the use of Glipon MF 20/500 Tablet safe during breastfeeding?
Taking Glipon MF may lead to serious side effects if you are breastfeeding. Glipon MF should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Glipon MF 20/500 Tablet on the Kidneys?
No research work has been carried out till date on effects of Glipon MF on kidney. So it is not known whether taking Glipon MF will cause side effects on kidney or not.
What is the effect of Glipon MF 20/500 Tablet on the Liver?
Information about safety of Glipon MF for the liver is not available since scientific research on this is yet to be done.
What is the effect of Glipon MF 20/500 Tablet on the Heart?
Information about safety of Glipon MF for heart is not available since scientific research on this is yet to be done.
Glipon MF 20/500 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glipon MF 20/500 Tablet unless your doctor advises you to do so -
Is this Glipon MF 20/500 Tablet habit forming or addictive?
Glipon MF 20/500 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Glipon MF 20/500 Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Glipon MF 20/500 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Glipon MF 20/500 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Glipon MF 20/500 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Glipon MF 20/500 Tablet together with food.
Interaction between Alcohol and Glipon MF 20/500 Tablet
Information about the interaction of Glipon MF 20/500 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826